Low Testosterone and Mental Health: Depression, Anxiety Risk
Testosterone under 300 ng/dL overlaps with depression and anxiety symptoms; men with low T face 2-4x higher depression rates, per Endocrine Society criteria.
Male Hypogonadism Monitoring Schedule: When to Test and What to Track on TRT
A detailed, guideline-based monitoring schedule for men on testosterone replacement therapy (TRT), covering baseline labs, 3-month check-ins, 6-month evaluations, and annual assessments per Endocrine Society and AUA recommendations.
Male Hypogonadism in Special Populations
Evidence-based guide to diagnosing and treating male hypogonadism in special populations including obesity, type 2 diabetes, HIV, opioid users, older men, chronic kidney disease, and cancer survivors.
Menopause Comorbidities: Conditions That Overlap With the Menopausal Transition
A guide to the most common comorbidities linked to menopause, including cardiovascular disease, osteoporosis, type 2 diabetes, depression, and genitourinary syndrome, with evidence-based treatment approaches.
Menopause Emerging Research and Trials to Watch
A clinical review of the most promising menopause research in 2024-2026, including NK3 receptor antagonists, estetrol, microbiome therapies, and updated guideline shifts.
Menopause Guidelines Compared: ADA, AACE, Endocrine Society, USPSTF, and NAMS
A side-by-side comparison of major society guidelines for menopause diagnosis, hormone therapy, and long-term management from NAMS, the Endocrine Society, AACE, ADA, and USPSTF.
Genetics and Family History Behind Menopause-Related Weight Gain
How your genes and family history influence weight gain during menopause, including key genetic variants, heritability estimates, and evidence-based strategies to manage hereditary risk.
Menopause-Related Weight Gain Guidelines Compared: ADA, AACE, Endocrine Society, NAMS, and USPSTF
A side-by-side comparison of major society guidelines on managing menopause-related weight gain, including pharmacotherapy thresholds, HRT recommendations, and lifestyle interventions from ADA, AACE, the Endocrine Society, NAMS, and USPSTF.
Menopause-Related Weight Gain and Mental Health: How Depression, Anxiety, and Stress Drive Midlife Body Composition Changes
Explore the bidirectional relationship between menopause-related weight gain and mental health conditions including depression, anxiety, and emotional eating, with evidence-based treatment strategies.
Metabolic Syndrome Monitoring Schedule: Exact Tests, Intervals, and Targets
A guideline-backed monitoring schedule for metabolic syndrome, including lab tests, visit intervals, and clinical targets from ADA, AACE, and the Endocrine Society.
Metabolic Syndrome Nutrition and Lifestyle Protocols: Evidence-Based Strategies
Evidence-based nutrition and lifestyle protocols for metabolic syndrome, including dietary patterns, exercise prescriptions, and behavioral interventions backed by major clinical trials and society guidelines.
NAFLD / MASLD Genetics and Family History
How genetic variants like PNPLA3, TM6SF2, and HSD17B13 influence NAFLD/MASLD risk, and what family history means for screening, diagnosis, and treatment decisions.
NAFLD / MASLD Exact Monitoring Schedule
Evidence-based monitoring schedule for NAFLD and MASLD, including lab frequency, imaging intervals, fibrosis staging, and when to refer to hepatology.
NAFLD / MASLD Nutrition and Lifestyle Protocols
Evidence-based nutrition and lifestyle interventions for metabolic-associated steatotic liver disease (MASLD/NAFLD), including dietary patterns, exercise prescriptions, and weight-loss targets backed by major clinical trials and society guidelines.
Exercise Prescription for Obesity (BMI ≥30): Evidence-Based Protocols and Guidelines
A guide to exercise prescription for adults with obesity (BMI ≥30), covering AHA, ACSM, and Endocrine Society recommendations with specific protocols, doses, and trial data.
Obesity (BMI ≥30) Exact Monitoring Schedule
A guideline-backed monitoring schedule for adults with obesity (BMI ≥30), covering lab work, vitals, metabolic panels, and follow-up intervals during pharmacotherapy and lifestyle intervention.
Obesity Treatment in Special Populations: Evidence-Based Approaches for Complex Patients
How obesity management differs for older adults, adolescents, pregnant patients, and those with CKD, diabetes, or psychiatric conditions. Guideline-backed strategies with trial data.
Obesity Treatment Algorithm: A Line-by-Line Guide to Evidence-Based Therapy
Step-by-step obesity treatment algorithm organized by line of therapy, from lifestyle intervention through pharmacotherapy and metabolic surgery, based on ADA, AACE, and Endocrine Society guidelines.
Obstructive Sleep Apnea Comorbidities: The Conditions That Overlap With OSA
Obstructive sleep apnea rarely travels alone. Learn which comorbidities overlap most with OSA, how they interact, and what the clinical evidence says about managing them together.
Obstructive Sleep Apnea Genetics and Family History: What Runs in Your Family
Obstructive sleep apnea has a strong genetic component. Learn how family history, inherited craniofacial traits, and specific gene variants increase OSA risk, and what screening steps to take.
Testosterone Therapy and Severe Untreated Sleep Apnea
Endocrine Society advises against testosterone therapy in untreated severe OSA. See this rule alongside ADA, AACE, AASM, and USPSTF guidance compared.
PCOS Emerging Research and Trials to Watch in 2026
A guide to the latest PCOS research, including GLP-1 receptor agonists, ovasitol, anti-Müllerian hormone diagnostics, and ongoing clinical trials for polycystic ovary syndrome.
Perimenopause Caregiver and Family Resources
Evidence-based guide for caregivers and families supporting someone through perimenopause, covering communication strategies, treatment literacy, mental health support, and clinical resources.
Perimenopause Diagnostic Algorithm: A Step-by-Step Clinical Guide
A step-by-step perimenopause diagnostic algorithm covering STRAW+10 staging, lab workup, differential diagnosis, and treatment initiation based on major society guidelines.
Perimenopause Guidelines Compared: ADA, AACE, Endocrine Society, USPSTF, and NAMS
A side-by-side comparison of major society guidelines for diagnosing and treating perimenopause, including hormone therapy recommendations from NAMS, the Endocrine Society, AACE, and USPSTF.
Perimenopause and Mental Health: How Hormonal Shifts Drive Anxiety, Depression, and Cognitive Changes
Estrogen fluctuations during perimenopause increase the risk of new-onset depression, anxiety, and brain fog. Learn how clinicians diagnose and treat the mental health overlap.
Perimenopause Nutrition and Lifestyle Protocols
Evidence-based nutrition, exercise, and lifestyle strategies for managing perimenopause symptoms, backed by major society guidelines and clinical trial data.
Post-Surgical Recovery: Caregiver and Family Resources
Evidence-based guide to caregiving after surgery, covering wound care, medication management, nutrition, mobility support, mental health, and when to call the surgeon.
Post-Surgical Recovery Diagnostic Algorithm: A Step-by-Step Clinical Framework
A structured framework for tracking post-surgical recovery across wound healing, pain trajectory, clot risk, nutrition, and function, with guidance on which findings warrant escalation and which reflect normal variation.
Prediabetes Caregiver and Family Resources
Evidence-based guide for caregivers and families supporting someone with prediabetes, including lifestyle strategies, screening recommendations, shared-risk awareness, and practical tools from the ADA, CDC, and major clinical trials.
Guidelines for Prediabetes Management and Diagnosis
ADA criteria: fasting glucose 100-125 mg/dL, A1c 5.7-6.4%, or OGTT 140-199 mg/dL. Screening starts at age 35. See the full diagnostic algorithm.
Prediabetes Exercise Prescription: Evidence-Based Protocols That Lower Your Risk
A guide to exercise protocols for prediabetes, including specific intensity targets, resistance training recommendations, and the trial data behind each prescription.
Management of Prediabetes Guidelines: Treatment Algorithm
Prediabetes management starts with lifestyle changes targeting 7% weight loss, then metformin for high-risk patients, then GLP-1 agonists if obesity persists.
Secondary Hypogonadism: Caregiver and Family Resources
A guide for caregivers and family members supporting someone with secondary hypogonadism, covering diagnosis, treatment options, emotional support strategies, and clinical resources.
Secondary Hypogonadism Guidelines Compared: Endocrine Society, AUA, AACE, ADA, and EAU
A side-by-side comparison of major society guidelines for diagnosing and treating secondary hypogonadism, including diagnostic thresholds, treatment algorithms, and fertility-preserving options.
Secondary Hypogonadism and Mental Health: How Low Testosterone Affects Depression, Anxiety, and Cognition
Secondary hypogonadism frequently co-occurs with depression, anxiety, and cognitive decline. Learn how hypothalamic-pituitary dysfunction links low testosterone to mental health conditions, and what evidence-based treatments can help.
Tendinopathy and Mental Health: The Overlap Between Chronic Tendon Pain and Psychological Distress
Evidence-based guide on how tendinopathy intersects with depression, anxiety, and sleep disorders, plus integrated treatment strategies backed by clinical research.
Tendinopathy Monitoring Schedule: When to Reassess, What to Track, and When to Escalate
A week-by-week tendinopathy monitoring schedule covering VISA scores, load progression, imaging triggers, and escalation criteria based on current clinical evidence.
Is Type 2 Diabetes Genetic? What Your Family Risk Means
Yes, genetics play a role: one affected parent raises your risk to 40%, but over 400 genes explain only 20% of it. Lifestyle cuts risk 58%.
Type 2 Diabetes Guidelines Compared: ADA vs. AACE vs. Endocrine Society vs. USPSTF
A side-by-side comparison of ADA, AACE, Endocrine Society, and USPSTF guidelines for Type 2 Diabetes diagnosis, A1c targets, first-line therapy, and cardiovascular risk management.
Type 2 Diabetes Nutrition and Lifestyle Protocols
Evidence-based nutrition plans, exercise protocols, and lifestyle changes for managing type 2 diabetes, including ADA and AACE guideline recommendations, macronutrient targets, and meal timing strategies.
Dapagliflozin Renal Dose: eGFR Thresholds Explained
Dapagliflozin stays at 10 mg daily regardless of kidney function. Starts at eGFR ≥25; continue until dialysis or transplant. DAPA-CKD data included.
How to Safely Stop Prolia (Denosumab): Discontinuation Protocol
A guide to safely discontinuing Prolia (denosumab), including bisphosphonate bridging protocols, rebound fracture risks, bone turnover monitoring, and step-by-step transition timelines.
Prolia (Denosumab) Monitoring Schedule: Labs & Exams
Complete monitoring schedule for Prolia (denosumab), including baseline labs, calcium checks, DEXA timing, and adverse-effect screening, with PubMed-cited evidence.
Is Low Libido a Warning Sign? Understanding the Canary in the Coal Mine and How to Restore Your Vital Energy
Low libido can signal testosterone deficiency, cardiovascular disease, diabetes, or depression. Learn what declining sex drive really means and evidence-based ways to restore it.
What PCOS Actually Feels Like: Understanding the Symptoms and Solutions
PCOS causes irregular periods, acne, hair loss, weight gain, and mood changes. Learn what polycystic ovary syndrome really feels like day to day and which treatments work.
Trulicity (Dulaglutide) Adult Dosing: Complete Guide for Ages 30 to 49
Evidence-based Trulicity (dulaglutide) dosing guide for adults aged 30, 49 with type 2 diabetes. Covers starting dose, titration schedule, injection technique, missed-dose rules, and real-world clinical considerations.
Trulicity (Dulaglutide) Safety in Adults Aged 30 to 49: What the Evidence Shows
A guide to dulaglutide (Trulicity) safety for adults aged 30 to 49, covering GI side effects, cardiovascular data from REWIND, pancreatitis risk, thyroid warnings, and practical monitoring advice.
Trulicity (Dulaglutide) Food & Supplement Interactions: What to Eat, Avoid, and Monitor
Evidence-based guide to dulaglutide (Trulicity) food and supplement interactions, including effects on nutrient absorption, alcohol, fiber, and common vitamins.
Trulicity (Dulaglutide) Dosing in Hepatic Impairment
Evidence-based guide to dulaglutide (Trulicity) dosing in patients with hepatic impairment, including pharmacokinetic data, clinical recommendations, and liver safety monitoring.
Trulicity Missed-Dose Protocol: What to Do When You Skip a Dulaglutide Injection
Evidence-based protocol for managing a missed Trulicity (dulaglutide) dose, including timing thresholds, double-dose risks, and how to get back on schedule safely.
Trulicity (Dulaglutide) Patent Status & Generic Timeline: What to Expect
A clinical review of dulaglutide (Trulicity) patent filings, exclusivity windows, biosimilar development, and projected generic availability for patients with type 2 diabetes.
Trulicity (Dulaglutide) Pediatric Dosing for Children Under 12
Evidence-based guide to dulaglutide (Trulicity) use in children under 12, including current FDA labeling, off-label considerations, weight-based dosing data, and safer alternatives for pediatric type 2 diabetes.
Trulicity (Dulaglutide) Real-World Evidence: What Registries and RWE Studies Actually Show
A physician-level review of dulaglutide (Trulicity) real-world evidence from registries, claims databases, and post-marketing studies, including REWIND cardiovascular data and adherence outcomes.
Trulicity (Dulaglutide) Dosing in Renal Impairment: What the Evidence Actually Shows
Evidence-based guide to dulaglutide (Trulicity) dosing across all stages of renal impairment, including CKD stages 3-5 and dialysis, with FDA label data, REWIND renal outcomes, and AWARD trial pharmacokinetics.
Trulicity (Dulaglutide) Safety Signals and FDA Actions: What Patients and Clinicians Need to Know
A comprehensive review of dulaglutide (Trulicity) safety signals, FDA regulatory actions, boxed warnings, postmarketing surveillance findings, and clinical trial safety data from REWIND and AWARD trials.
How to Self-Inject Trulicity (Dulaglutide): Step-by-Step Technique, Tips, and Troubleshooting
A guide to Trulicity (dulaglutide) self-injection technique, covering pen anatomy, site selection, injection steps, needle-free design, and how to avoid common errors.
Trulicity (Dulaglutide) in Special Populations: Transplant, HIV, and Beyond
Evidence-based guide to using dulaglutide (Trulicity) in transplant recipients, people living with HIV, older adults, and other special populations. Includes dosing, safety data, and clinical considerations.
Does TRICARE Cover Trulicity? Formulary Tier, Prior Authorization, and Appeal Steps
TRICARE covers Trulicity (dulaglutide) for type 2 diabetes with prior authorization. Learn the formulary tier, step therapy rules, PA criteria, appeal process, and out-of-pocket costs for military beneficiaries.
Is Dutasteride (Avodart) Safe for Adolescents Ages 12 to 17?
Dutasteride (Avodart) is not FDA-approved for adolescents. This article covers DHT's role in puberty, known adult adverse effects, reproductive development risks, mental health concerns, and monitoring protocols for off-label adolescent use.
